[1]
S. Elyasi, A. Allahyari, M. Sheikhvanloo, M. Jannati, F. Kalalinia, and A. H. Mohamadpoor, “Evaluation of Correlation Between Serum Level of Dihydropyrimidine Dehydrogenase Enzyme and Capecitabine Induced Adverse Reaction”, Reports-of-Radiotherapy-and-Onco, vol. 4, no. 1, pp. 1-6, Aug. 2018.